PPARG and hepatocellular carcinoma: Moreover, celecoxib has been reported to stimulate PPARγ as well as PTEN, the endogenous antagonist of Akt signaling, in hepatoma cells [20], we investigated whether this signaling pathway affects the therapeutic mechanism of celecoxib for Novikoff hepatoma.